Skip to main content
Signal8
Dash Barry H profile photo

Barry H. Dash

CIK: 0001324222

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELITE PHARMACEUTICALS INC /NV/ logo
ELTP

ELITE PHARMACEUTICALS INC /NV/

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ELITE PHARMACEUTICALS INC /NV/ logo
    ELTP

    ELITE PHARMACEUTICALS INC /NV/

    Oct 9, 2026
    Purchase(P)
    Direct
    100K shares at avg. $0.26$26K
  • ELITE PHARMACEUTICALS INC /NV/ logo
    ELTP

    ELITE PHARMACEUTICALS INC /NV/

    Aug 19, 2026
    Purchase(P)
    Direct
    30K shares at avg. $0.29$9K

1-2 of 2

About Dash Barry H

Dash Barry H (SEC CIK 0001324222) files insider reports with the SEC as Director of ELITE PHARMACEUTICALS INC /NV/ (ELTP).

Signal8 holds 2 ownership filings by Dash Barry H, all Form 4s, filed between Sep 10, 2026 and Oct 19, 2026. Those filings report 2 transactions, from Aug 19, 2026 to Oct 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dash Barry H's filings is in NORTHVALE, NJ.

Recent filings by Dash Barry H

  • Oct 9, 2026: Open-market purchase of ELTP shares (Form 4, code P).
  • Aug 19, 2026: Open-market purchase of ELTP shares (Form 4, code P).

Other insiders filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP)

How to read Form 4 transaction codes